Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$3.79
-5.81%
Mkt Cap $83.09M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+216.9%
Consensus $12.00 vs current $3.79
NASDAQ·Healthcare·Biotechnology
$3.79
-5.81%
Mkt Cap $83.09M
No recent rating data.
Price Target (2 analysts)
$12.00
Range $12.00 – $12.00
+216.9%
Consensus $12.00 vs current $3.79